Philips, a global leader in health technology, and Medtronic, a pioneer in medical technology, have signed a Memorandum of Understanding (MoU) in India to provide specialized training for cardiologists and radiologists in advanced imaging techniques for structural heart diseases.
This collaboration aims to enhance expertise in multi-modality imaging, including echocardiography (echo) and Magnetic Resonance Imaging (MRI), particularly for End-Stage Renal Disease (ESRD) patients.
Advancing Medical Education with Cutting-Edge Technology
The initiative will upskill over 300 clinicians through a mix of theoretical and hands-on training using Philips’ state-of-the-art ultrasound and MRI systems. International and Indian medical experts will guide the training sessions at 15 premier medical institutions specializing in structural heart procedures.
“At Philips, our priority is to enhance patient care through innovation and education,” said Bharath Sesha, Managing Director of Philips Indian Subcontinent. “This collaboration with Medtronic will equip clinicians with advanced imaging techniques, leading to more accurate diagnoses and improved treatment outcomes, particularly for ESRD patients.”
Mandeep Singh Kumar, Managing Director and Vice President of Medtronic India, echoed this sentiment, stating, “Our partnership with Philips is a significant step in our commitment to advancing cardiovascular care. By providing specialized training in advanced imaging, we aim to improve the precision of Transcatheter Aortic Valve Implantation (TAVI) procedures and ultimately enhance patient outcomes.”
Addressing India’s Growing ESRD Burden
With approximately 2.2 lakh new cases of ESRD diagnosed annually in India, the demand for advanced diagnostic solutions is critical. Global studies indicate that 9.5% of ESRD patients with Aortic Stenosis can significantly benefit from advanced imaging technologies during Transcatheter Aortic Valve Replacement (TAVR).
ALSO READ: BSES, AWPO launch drone pilot training programme for armed forces veterans, veer naaris
Medtronic’s TAVR system recently celebrated two decades since its first-in-human procedure in 2004. Over the years, Medtronic has introduced groundbreaking TAVR systems in India, continuously improving the landscape of minimally invasive heart valve replacement.
AI-Driven Innovation for Improved Patient Outcomes
Philips’ AI-driven software, capable of analyzing aortic anatomy using data from 3D transesophageal echocardiography (3D TEE) and MRI, eliminates the need for radiopaque contrast agents. This is particularly beneficial for ESRD patients, as contrast agents can be nephrotoxic and further impair kidney function.
By leveraging cutting-edge imaging solutions and specialized training, the Philips-Medtronic partnership is poised to make a lasting impact on cardiac care in India, improving both the duration and quality of life for patients with structural heart diseases.
